FDA Finalizing Phase-Out Of CFC-Using Inhalers – Wall Street Journal

FDA Finalizing Phase-Out Of CFC-Using Inhalers
Wall Street Journal
Asthma sufferers who use the inhalers should plan to get a prescription for a replacement product, the agency said. The Primatene Mist epinephrine inhalers, marketed by Armstrong Pharmaceutical Inc., are the only FDA-approved inhalers sold over the
FDA: Over-the-Counter Asthma Inhalers Containing Chloroflouorocarbons (CFCs MarketWatch (press release)
FDA Phases out Inhaler Due to Environmental ImpactABC News
FDA: Over-the-counter asthma inhalers containing chloroflouorocarbons (CFCs MMD Newswire (press release)

all 11 news articles »

View full post on asthma – Google News